Temozolomide and Concomitant Whole Brain Radiotherapy in NSCLC Patients With Brain Metastases

NCT02385136 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

135

Enrollment

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Temozolomide

Sponsor

Zhejiang Cancer Hospital

Collaborators

[object Object]